Reported 5 days ago
Billionaire Ken Griffin has significantly increased his stake in Pfizer, a high-yield dividend stock, as part of his Citadel hedge fund's investment strategy. Despite not being an income-focused investor, Griffin purchased nearly 8 million additional shares of Pfizer, boosting his holdings by 63%. The company offers a dividend yield of 5.8% and remains undervalued compared to its healthcare peers. While good for value and income investors, potential buyers should consider their investment goals, as Pfizer may not suit growth-oriented investors.
Source: YAHOO